Preclinical Services for HIV Therapeutics
Award Notice Posted
- Solicitation number
- 75N93019R00021
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93021D00011-75N93021F00001 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance
- Galveston Tx Usa
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice announces a multiple award, Indefinite Delivery/Indefinite Quantity contract for preclinical services for HIV therapeutics awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The University of Texas Medical Branch at Galveston was awarded a contract valued at $107,274,471 for a seven year ordering period from October 15, 2020 through October 14, 2027 to provide preclinical services under Task Area D. Cost-reimbursement task orders are anticipated to be the primary type issued, though fixed-price orders may be used where appropriate.
Notice text
A competitive multiple award, Indefinite Delivery/Indefinite Quantity (IDIQ) type contract was awarded, with a seven year ordering period (October 15, 2020 through October 14, 2027). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-driven) requirement into a fixed-price environment. In these instances, fixed-price task orders would be disadvantageous to the Government, since they do not provide the Government with the flexibility that is needed to responsively and responsibly shift with the evolving needs of this requirement. However, fixed-price Task Orders may be issued, where appropriate and feasible. The Contractor is eligible for Task Orders under Task Area D.
Awarded contract 75N93021D00011 to UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON for 107274471.00 on 2020-10-15.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Preclinical Services for HIV Therapeutics | Award Notice | |
| Preclinical Services for HIV Therapeutics | Award Notice | |
| Preclinical Services for HIV Therapeutics | Award Notice | |
| This notice | Award Notice | |
| Preclinical Services for HIV Therapeutics | Solicitation | |
| Preclinical Services for HIV Therapeutics | Pre-Solicitation |
6 of 17 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity